Skip to content
The Policy VaultThe Policy Vault

Stivarga (regorafenib tablets - Bayer) — Cigna

Hepatocellular Carcinoma

Initial criteria

  • Patient age ≥ 18 years
  • Patient has been previously treated with one systemic regimen

Approval duration

1 year